55 North Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$890K Buy
3,402
+278
+9% +$71.3K 0.17% 66
2026
Q2
$786K Buy
3,124
+372
+14% +$80K 0.15% 70
2026
Q1
$598K Buy
2,752
+100
+4% +$22.2K 0.15% 66
2025
Q4
$606K Buy
+2,652
New +$604K 0.16% 65

Other funds holding ABBV

55 North Private Wealth's ABBV Position: Q3 2026 in Review

55 North Private Wealth increased its AbbVie (ABBV) stake by 8.9% in Q3 2026, buying an estimated $71.3K and bringing the position to 3,402 shares worth $890K. The position accounts for 0.17% of the portfolio, ranked #66.

55 North Private Wealth first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • 55 North Private Wealth held 3,402 shares of AbbVie worth $890K as of Q3 2026.
  • 55 North Private Wealth bought 278 AbbVie shares in Q3 2026, an estimated $71.3K.
  • AbbVie made up 0.17% of 55 North Private Wealth's portfolio in Q3 2026, its #66 holding.
  • 55 North Private Wealth first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on 55 North Private Wealth's 13F filing for Q3 2026, filed 20 Oct 2026.